DrugPipeline.net has announced the addition of “Global Gout Therapeutics Market 2016-2020” research report to their website DrugPipeline.net

Bangalore, Karnataka -- (SBWire) -- 12/12/2016 --Gout is one type of arthritis, which is caused by the high levels of uric acid in the blood. The main symptoms of gout are sudden attack of burning pain, swelling in a joint, and stiffness, usually in toe. If it is not treated, over time, it can harm tendons, joints, and other tissues. NSAIDs and urate-lowering agents are preferred treatment options for gout.

Report forecast the global gout therapeutics market to grow at a CAGR of 17.16% during the period 2016-2020.

The report covers the present scenario and the growth prospects of the global gout therapeutics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-label drugs used for the treatment of gout and the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Global Gout Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- AstraZeneca
- Horizon Pharma
- Takeda Pharmaceuticals

Other prominent vendors
- Ablynx
- Alder Biopharmaceuticals
- Antares Pharma
- Astellas Pharma
- Boehringer Ingelheim
- Can-Fite BioPharma
- Celgene
- Celltrion
- ChemoCentryx
- CymaBay Therapeutics
- Eisai
- Eli Lilly
- Gilead Sciences
- GlaxoSmithKline
- Incyte
- Ironwood Pharmaceuticals
- JW Pharmaceutical
- KaloBios Pharmaceuticals
- Lexicon Pharmaceuticals
- LG Life Sciences
- Merck
- Morphotek
- Novartis
- Novo Nordisk
- Regeneron Pharmaceuticals
- Sandoz
- Sanofi
- Santarus
- Selecta Biosciences
- Teijin Pharma
- UCB
- Vertex Pharmaceuticals.

Market driver
- Introduction of novel urate-lowering agents
- For a full, detailed list, view our report

Market challenge
- Low physician and patient awareness
- For a full, detailed list, view our report

Market trend
- Focus on regenerative medicines
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Spanning over 83 pages "Global Gout Therapeutics Market 2016-2020" report covers Executive summary, Scope of the report, Market research methodology, Introduction, Gout: Disease overview, Market landscape, Key buying criteria, Market segmentation by drug class, Market segmentation by type of disease, Geographical segmentation, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Key vendor analysis, Appendix.

For more information Visit at: http://www.drugpipeline.net/technavio/global-gout-therapeutics-market-2016-2020

About DrugPipeline.net
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.